Year |
Citation |
Score |
2024 |
Kashyap SN, Fox SN, Wilson KI, Murchison CF, Ambaw YA, Walther TC, Farese RV, Arrant AE, Roberson ED. Carboxy-terminal blockade of sortilin binding enhances progranulin gene therapy, a potential treatment for frontotemporal dementia. Biorxiv : the Preprint Server For Biology. PMID 39345608 DOI: 10.1101/2024.09.15.613118 |
0.747 |
|
2024 |
Cook AK, Greathouse KM, Manuel PN, Cooper NH, Eberhardt JM, Freeman CD, Weber AJ, Herskowitz JH, Arrant AE. Dendritic spine head diameter is reduced in the prefrontal cortex of progranulin haploinsufficient mice. Molecular Brain. 17: 33. PMID 38840181 DOI: 10.1186/s13041-024-01095-5 |
0.36 |
|
2023 |
Kaplelach AK, Fox SN, Cook AK, Hall JA, Dannemiller RS, Jaunarajs KL, Arrant AE. Regulation of extracellular progranulin in medial prefrontal cortex. Neurobiology of Disease. 188: 106326. PMID 37838007 DOI: 10.1016/j.nbd.2023.106326 |
0.739 |
|
2023 |
Kurnellas M, Mitra A, Schwabe T, Paul R, Arrant AE, Roberson ED, Ward M, Yeh F, Long H, Rosenthal A. Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia. Journal of Translational Medicine. 21: 387. PMID 37322482 DOI: 10.1186/s12967-023-04251-y |
0.562 |
|
2023 |
Davis SE, Cook AK, Hall JA, Voskobiynyk Y, Carullo NV, Boyle NR, Hakim AR, Anderson KM, Hobdy KP, Pugh DA, Murchison CF, McMeekin LJ, Simmons M, Margolies KA, Cowell RM, ... ... Arrant AE, et al. Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations. Acta Neuropathologica Communications. 11: 70. PMID 37118844 DOI: 10.1186/s40478-023-01571-4 |
0.741 |
|
2021 |
Davis SE, Roth JR, Aljabi Q, Hakim AR, Savell KE, Day JJ, Arrant AE. Delivering progranulin to neuronal lysosomes protects against excitotoxicity. The Journal of Biological Chemistry. 100993. PMID 34298019 DOI: 10.1016/j.jbc.2021.100993 |
0.472 |
|
2020 |
Arrant AE, Davis SE, Vollmer RM, Murchison CF, Mobley JA, Nana AL, Spina S, Grinberg LT, Karydas AM, Miller BL, Seeley WW, Roberson ED. Elevated levels of extracellular vesicles in progranulin-deficient mice and FTD-GRN Patients. Annals of Clinical and Translational Neurology. PMID 33197149 DOI: 10.1002/acn3.51242 |
0.634 |
|
2019 |
Arrant AE, Roth JR, Boyle NR, Kashyap SN, Hoffmann MQ, Murchison CF, Ramos EM, Nana AL, Spina S, Grinberg LT, Miller BL, Seeley WW, Roberson ED. Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations. Acta Neuropathologica Communications. 7: 218. PMID 31870439 DOI: 10.1186/S40478-019-0872-6 |
0.722 |
|
2019 |
Stoyka LE, Arrant AE, Thrasher DR, Russell DL, Freire J, Mahoney CL, Narayanan A, Dib AG, Standaert DG, Volpicelli-Daley LA. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions. Neurobiology of Disease. 104708. PMID 31837424 DOI: 10.1016/J.Nbd.2019.104708 |
0.401 |
|
2019 |
Arrant AE, Boyle NR, Roth JR, Li AN, Spina S, Grinberg LT, Miller BL, Seeley WW, Roberson ED. P1-186: IMPAIRED β-GLUCOCEREBROSIDASE ACTIVITY AND PROCESSING IN FRONTOTEMPORAL DEMENTIA DUE TO PROGRANULIN MUTATIONS Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.741 |
0.587 |
|
2018 |
Arrant AE, Filiano AJ, Patel AR, Hoffmann MQ, Boyle NR, Kashyap SN, Onyilo VC, Young AH, Roberson ED. Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice. Neurobiology of Disease. PMID 30448285 DOI: 10.1016/J.Nbd.2018.11.011 |
0.734 |
|
2018 |
Arrant AE, Nicholson AM, Zhou X, Rademakers R, Roberson ED. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency. Molecular Neurodegeneration. 13: 32. PMID 29929528 DOI: 10.1186/S13024-018-0264-6 |
0.612 |
|
2018 |
Arrant AE, Onyilo VC, Unger DE, Roberson ED. Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29378861 DOI: 10.1523/Jneurosci.3081-17.2018 |
0.673 |
|
2017 |
Arrant AE, Filiano AJ, Unger DE, Young AH, Roberson ED. Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia. Brain : a Journal of Neurology. PMID 28379303 DOI: 10.1093/Brain/Awx060 |
0.777 |
|
2016 |
Arrant AE, Filiano AJ, Warmus BA, Hall AM, Roberson ED. Progranulin haploinsufficiency causes biphasic social dominance abnormalities in the tube test. Genes, Brain, and Behavior. PMID 27213486 DOI: 10.1111/Gbb.12300 |
0.742 |
|
2016 |
Gentry EG, Henderson BW, Arrant AE, Gearing M, Feng Y, Riddle NC, Herskowitz JH. Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 1316-23. PMID 26818518 DOI: 10.1523/Jneurosci.2336-15.2016 |
0.304 |
|
2015 |
Arrant AE, Patel AR, Roberson ED. Effects of Exercise on Progranulin Levels and Gliosis in Progranulin-Insufficient Mice. Eneuro. 2. PMID 26361634 DOI: 10.1523/ENEURO.0061-14.2015 |
0.528 |
|
2015 |
Sánchez CL, Van Swearingen AE, Arrant AE, Biskup CS, Kuhn CM, Zepf FD. Simplified dietary acute tryptophan depletion: effects of a novel amino acid mixture on the neurochemistry of C57BL/6J mice. Food & Nutrition Research. 59: 27424. PMID 26278978 DOI: 10.3402/Fnr.V59.27424 |
0.778 |
|
2014 |
Arrant AE, Roberson ED. MicroRNA-124 modulates social behavior in frontotemporal dementia. Nature Medicine. 20: 1381-3. PMID 25473917 DOI: 10.1038/Nm.3768 |
0.538 |
|
2014 |
Ward ME, Taubes A, Chen R, Miller BL, Sephton CF, Gelfand JM, Minami S, Boscardin J, Martens LH, Seeley WW, Yu G, Herz J, Filiano AJ, Arrant AE, Roberson ED, et al. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. The Journal of Experimental Medicine. 211: 1937-45. PMID 25155018 DOI: 10.1084/Jem.20140214 |
0.768 |
|
2014 |
Sánchez CL, Van Swearingen AE, Arrant AE, Kuhn CM, Zepf FD. Dietary manipulation of serotonergic and dopaminergic function in C57BL/6J mice with amino acid depletion mixtures. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 153-62. PMID 24061481 DOI: 10.1007/S00702-013-1083-0 |
0.762 |
|
2013 |
Arrant AE, Coburn E, Jacobsen J, Kuhn CM. Lower anxiogenic effects of serotonin agonists are associated with lower activation of amygdala and lateral orbital cortex in adolescent male rats. Neuropharmacology. 73: 359-67. PMID 23774134 DOI: 10.1016/J.Neuropharm.2013.05.030 |
0.523 |
|
2013 |
Arrant AE, Schramm-Sapyta NL, Kuhn CM. Use of the light/dark test for anxiety in adult and adolescent male rats. Behavioural Brain Research. 256: 119-27. PMID 23721963 DOI: 10.1016/J.Bbr.2013.05.035 |
0.499 |
|
2013 |
Arrant AE, Jemal H, Kuhn CM. Adolescent male rats are less sensitive than adults to the anxiogenic and serotonin-releasing effects of fenfluramine. Neuropharmacology. 65: 213-22. PMID 23103347 DOI: 10.1016/J.Neuropharm.2012.10.010 |
0.521 |
|
2012 |
Biskup CS, Sánchez CL, Arrant A, Van Swearingen AE, Kuhn C, Zepf FD. Effects of acute tryptophan depletion on brain serotonin function and concentrations of dopamine and norepinephrine in C57BL/6J and BALB/cJ mice. Plos One. 7: e35916. PMID 22629305 DOI: 10.1371/Journal.Pone.0035916 |
0.77 |
|
2012 |
Walker QD, Johnson ML, Van Swearingen AE, Arrant AE, Caster JM, Kuhn CM. Individual differences in psychostimulant responses of female rats are associated with ovarian hormones and dopamine neuroanatomy. Neuropharmacology. 62: 2267-77. PMID 22342988 DOI: 10.1016/J.Neuropharm.2012.01.029 |
0.723 |
|
2010 |
Walker QD, Morris SE, Arrant AE, Nagel JM, Parylak S, Zhou G, Caster JM, Kuhn CM. Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats. The Journal of Pharmacology and Experimental Therapeutics. 335: 124-32. PMID 20605908 DOI: 10.1124/Jpet.110.167320 |
0.69 |
|
2006 |
Arrant AE, Onyilo VC, Unger DE, Roberson ED. O4-05-01: PROGRANULIN GENE THERAPY IMPROVES PATHOLOGY AND REVERSES SOCIAL DEFICITS IN MOUSE MODELS OF FRONTOTEMPORAL DEMENTIA AND NEURONAL CEROID LIPOFUSCINOSIS DUE TO PROGRANULIN MUTATIONS Alzheimer's & Dementia. 14: P1411-P1411. DOI: 10.1016/J.Jalz.2018.06.2933 |
0.599 |
|
Show low-probability matches. |